Intelligence · Patents
Patents expiring in 2027
Annual patent cliff calendar for 2027 — US pharmaceutical patents by expiration date.
- Patents
- 599
Quick answer
599 indexed pharmaceutical patents have expiration dates in 2027. Browse by soonest expiry with links to assignee companies and related drugs.
-
US 7160867
Rapamycin carbohydrate derivatives
granted -
US 7161012
Processes for preparing amorphous atorvastatin hemi-calcium
granted -
US 7160984
Process for preparing glycopeptide derivatives
granted -
US 7161003
Pyrazolopyrimidines as cyclin dependent kinase inhibitors
granted -
US 7160720
CHAMP—a novel cardiac helicase-like factor
granted -
US 7160375
Aqueous glittering color material composition
granted -
US 7160722
Master bone formation transcription factor: compositions and methods of use
granted -
US 7160887
Aromatic amine derivatives, their production and use
granted -
US 7160868
Nr-CAM gene, nucleic acids and nucleic acid products for therapeutic and diagnostic uses for tumors
granted -
US 7160726
Compositions comprising conditioned cell culture media and uses thereof
granted -
US 7161059
Human hookworm model and method for maintaining human hookworm in a non-human primate
granted -
US 7163934
Methods for treating delirium glucocorticoid receptor-specific antagonists
granted -
US 7163824
Regulation of endogenous gene expression in cells using zinc finger proteins
granted -
US 7163925
p16 expression constructs and their application in cancer therapy
granted -
US 7163673
Sunscreen reagents from hydroxy-substituted acylglycerides
granted -
US 7163806
Somatic cells with ablated PrP gene and methods of use
granted -
US 7163700
Amorphous drug beads
granted -
US 7163935
Scorpionate-like pendant macrocyclic ligands, complexes and compositions thereof, and methods of using same
granted -
US 7163946
5-substituted 7,9-difluoro-5H-chromeno[3,4-f]quinoline compounds as selective progesterone receptor modulator compounds
granted -
US 7164000
RANTES mutants and therapeutic applications thereof
granted -
US 7163686
Protein A based binding domains with desirable activities
granted -
US 7163678
Reovirus for the treatment of ral-mediated cellular proliferative disorders
granted -
US 7163818
Bacteriophage having multiple host range
granted -
US 7166704
Antibodies immunologically specific for PD2, a protein that is amplified and overexpressed in pancreatic cancer
granted -
US 7166721
Preparation of 1H-imidazo[4,5-C] quinolin 4-amines via novel 1H-imidazo[4,5-c] quinolin 4-cyano and 1H-imidazo[4,5-c] quinolin 4-carboxamide intermediates
granted -
US 7166578
Orally administered peptides synergize statin activity
granted -
US 7166619
Prenylation inhibitors and methods of their synthesis and use
granted -
US 7166450
Hyaluronan synthase gene and uses thereof
granted -
US 7166584
Cholesterol transport gene
granted -
US 7166588
Derivatives and analogs of galanthamine
granted -
US 7166762
Method of constructing heart failure model animal
granted -
DK 0759786
Somatostatinbindende peptidmetal-chelatkonjugater
granted -
US 7169798
Inhibitors of c-Jun N terminal kinases (JNK) and other protein kinases
granted -
US 7169800
Imidazole compositions useful as inhibitors of protein kinases
granted -
US 7169801
Histone deacetylase inhibitors
granted -
US 7169779
Inhibitors of p38
granted -
US 7169411
Composition for delivery of biological agents and methods for the preparation thereof
granted -
US 7169799
Process for producing crystal
granted -
US 7169594
Diagnosis and treatment of diseases arising from defects in the tuberous sclerosis pathway
granted -
US 7169726
Catalyst for isomerization of solid fischer-tropsch paraffins and method for its production
granted -
US 7169815
3-methoxybenzyl thiourea derivatives and improved lipid compositions containing same
granted -
US 7169384
Tumor suppressor CAR-1
granted -
US 7173112
Antibody to GALP and uses thereof
granted -
US 7172869
Methods for transfecting T cells
granted -
US 7173039
Protein kinase inhibitors
granted -
US 7173027
Receptor selective cannabimimetic aminoalkylindoles
granted -
US 7172761
Polyvalent immunogen
granted -
US 7172768
Storage stable powder compositions of interleukin-4 receptor
granted
Frequently asked questions
How many pharma patents expire in 2027?
599 published patents in our USPTO index have expiration dates falling in calendar year 2027.